← Back to All US Stocks

Omeros Corp. (OMER) Fundamental Analysis & AI Grade 2026

OMER Nasdaq Pharmaceutical Preparations WA CIK: 0001285819
Recently Updated • Analysis: May 23, 2026 • SEC Data: 2026-03-31
Combined AI Grade
D
87% Confidence
STRONG AGREEMENT
D
92% Conf
D
82% Conf

📊 OMER Key Takeaways

Revenue: $9.9M
Net Margin: 566.7%
Free Cash Flow: $-14.5M
Current Ratio: 3.03x
Debt/Equity: N/A
EPS: $0.62
AI Grade: D with 92% confidence
Omeros Corp. (OMER) receives a D fundamental grade with 87% confidence from our AI analysis based on SEC 10-K filings. With revenue of $9.9M, net profit margin of 566.7%, Omeros Corp. demonstrates mixed fundamentals in the Healthcare sector. Below is our complete OMER stock analysis for 2026.

Is Omeros Corp. (OMER) a Good Investment?

Claude

Omeros faces critical solvency challenges with negative stockholders equity of -$63.3M and insufficient cash reserves ($1.9M) relative to operational cash burn (-$14.5M). Core business operations are deeply unprofitable with $17.4M operating losses on only $9.9M revenue, while the positive net income appears driven by non-operating gains masking fundamental operational distress. With minimal liquidity runway and substantial debt obligations ($87.9M), the company faces imminent refinancing pressures and potential dilutive capital raises.

ChatGPT

Despite ~$80M in revenue, Omeros posts very large operating losses and deeply negative free cash flow, leading to negative equity and weak interest coverage. A small cash balance relative to burn implies a short runway and a high probability of dilutive or costly financing. The improved net loss appears driven by non-operating items rather than sustainable operating performance.

Omeros Corp. Key Strengths (OMER)

Claude
  • + Positive net income of $56.1M suggests access to non-operating gains or strategic asset monetization
  • + Total assets of $286.2M provide some balance sheet cushion for potential restructuring
  • + Current ratio of 3.03x indicates near-term working capital for immediate obligations
ChatGPT
  • + Established revenue base (~$80M) in a typically pre-revenue sector
  • + Strong current and quick ratios indicating near-term liquidity coverage
  • + Minimal capital expenditure requirements

OMER Stock Risks: Omeros Corp. Investment Risks

Claude
  • ! Negative stockholders equity of -$63.3M indicates technical insolvency and balance sheet deterioration
  • ! Critical cash burn: $1.9M cash with -$14.5M annual operating cash flow creates 1-2 month runway risk
  • ! Operations unviable: -$176.1% operating margin with $9.9M revenue insufficient to support $17.4M operating losses
  • ! Debt servicing unsustainable: $87.9M debt cannot be supported by negative operating cash flow; interest coverage of -0.8x
  • ! Non-operating gains masking operational failure and likely unsustainable in future periods
  • ! High probability of dilutive equity financing, covenant violations, or restructuring
ChatGPT
  • ! Severe operating losses and -$116M operating cash outflow indicate unsustainable burn
  • ! Negative stockholders’ equity and -5.7x interest coverage signal solvency risk
  • ! Small cash balance versus burn implies imminent financing need and dilution risk

Key Metrics to Watch

Claude
  • * Quarterly cash balance trend and burn rate - watch for sub-$1M threshold indicating imminent crisis
  • * Operating cash flow recovery (currently -$14.5M) - must turn positive for viability
  • * Revenue growth and operating margin improvement - currently unprofitable core business
  • * Debt refinancing announcements - essential given negative equity and cash burn trajectory
  • * Form 8-K filings for material events - likely restructuring, dilutive financing, or bankruptcy risks
ChatGPT
  • * Operating cash flow (burn rate)
  • * Cash and equivalents (liquidity runway)

Omeros Corp. (OMER) Financial Metrics & Key Ratios

Revenue
$9.9M
Net Income
$56.1M
EPS (Diluted)
$0.62
Free Cash Flow
$-14.5M
Total Assets
$286.2M
Cash Position
$1.9M

💡 AI Analyst Insight

Strong liquidity with a 3.03x current ratio provides a solid financial cushion.

OMER Profit Margin, ROE & Profitability Analysis

Gross Margin N/A
Operating Margin -176.1%
Net Margin 566.7%
ROE N/A
ROA 19.6%
FCF Margin -146.6%

OMER vs Healthcare Sector: How Omeros Corp. Compares

How Omeros Corp. compares to Healthcare sector averages

Net Margin
OMER 566.7%
vs
Sector Avg 12.0%
OMER Sector
ROE
OMER 0.0%
vs
Sector Avg 15.0%
OMER Sector
Current Ratio
OMER 3.0x
vs
Sector Avg 2.0x
OMER Sector
Debt/Equity
OMER 0.0x
vs
Sector Avg 0.6x
OMER Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Omeros Corp. Stock Overvalued? OMER Valuation Analysis 2026

Based on fundamental analysis, Omeros Corp. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
N/A
Sector avg: 15%
Net Profit Margin
566.7%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
N/A
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Omeros Corp. Balance Sheet: OMER Debt, Cash & Liquidity

Current Ratio
3.03x
Quick Ratio
3.03x
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
-0.81x
Long-term Debt
$87.9M

OMER Revenue & Earnings Growth: 5-Year Financial Trend

OMER 5-year financial data: Year 2016: Revenue $41.6M, Net Income N/A, EPS N/A. Year 2017: Revenue $64.8M, Net Income N/A, EPS N/A. Year 2018: Revenue $64.8M, Net Income N/A, EPS N/A. Year 2019: Revenue $111.8M, Net Income N/A, EPS N/A. Year 2020: Revenue $111.8M, Net Income N/A, EPS N/A.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Omeros Corp.'s revenue has grown significantly by 169% over the 5-year period, indicating strong business expansion. The most recent EPS of $-1.88 indicates the company is currently unprofitable.

OMER Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-146.6%
Free cash flow / Revenue

OMER Quarterly Earnings & Performance

Quarterly financial performance data for Omeros Corp. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q1 2026 N/A -$33.5M $-0.58
Q3 2021 $26.1M -$22.7M $-0.36
Q2 2021 $13.5M -$28.6M $-0.46
Q1 2021 $21.1M -$29.0M N/A
Q3 2020 $26.1M -$14.5M N/A
Q2 2020 $13.5M -$14.5M N/A
Q1 2020 $21.8M -$24.3M N/A
Q3 2019 $4.6M -$14.5M N/A

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

Omeros Corp. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
-$14.5M
Cash generated from operations
Stock Buybacks
$4.2M
Shares repurchased (TTM)
Dividends
None
No dividend program

OMER SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Omeros Corp. (CIK: 0001285819)

📋 Recent SEC Filings

Date Form Document Action
May 27, 2026 4 xslF345X06/rdgdoc.xml View →
May 13, 2026 10-Q omer20260331_10q.htm View →
May 13, 2026 8-K omer20260403_8k.htm View →
Apr 30, 2026 DEF 14A e26114_omer-def14a.htm View →
Mar 31, 2026 10-K omer20251231_10k.htm View →

Frequently Asked Questions about OMER

What is the AI rating for OMER?

Omeros Corp. (OMER) has a Combined AI Grade of D from Claude (D) and ChatGPT (D) with 87% combined confidence, based on fundamental analysis of SEC EDGAR filings.

What are OMER's key strengths?

Claude: Positive net income of $56.1M suggests access to non-operating gains or strategic asset monetization. Total assets of $286.2M provide some balance sheet cushion for potential restructuring. ChatGPT: Established revenue base (~$80M) in a typically pre-revenue sector. Strong current and quick ratios indicating near-term liquidity coverage.

What are the risks of investing in OMER?

Claude: Negative stockholders equity of -$63.3M indicates technical insolvency and balance sheet deterioration. Critical cash burn: $1.9M cash with -$14.5M annual operating cash flow creates 1-2 month runway risk. ChatGPT: Severe operating losses and -$116M operating cash outflow indicate unsustainable burn. Negative stockholders’ equity and -5.7x interest coverage signal solvency risk.

What is OMER's revenue and growth?

Omeros Corp. reported revenue of $9.9M.

Does OMER pay dividends?

Omeros Corp. does not currently pay dividends.

Where can I find OMER SEC filings?

Official SEC filings for Omeros Corp. (CIK: 0001285819) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is OMER's EPS?

Omeros Corp. has a diluted EPS of $0.62.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.

What is OMER's fundamental grade?

Based on our AI fundamental analysis in May 2026, Omeros Corp. has a D grade with 87% confidence. Review the strengths and risks sections above for full context. This is not investment advice.

Is OMER stock overvalued or undervalued?

Valuation metrics for OMER: ROE of N/A (sector avg: 15%), net margin of 566.7% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

What is OMER's AI grade for 2026?

Our dual AI analysis gives Omeros Corp. a combined D grade for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.

What is OMER's free cash flow?

Omeros Corp.'s operating cash flow is $-14.5M, with capital expenditures of $0.0. FCF margin is -146.6%.

How does OMER compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin 566.7% (avg: 12%), ROE N/A (avg: 15%), current ratio 3.03 (avg: 2).

Top Rated Stocks
AAPL 92% MSFT 92% FAST 92% ANET 88% RDDT 88% KNSL 88% MGRE 88% FIZZ 88% DECK 87% NVDA 87%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: May 23, 2026 | Data as of: 2026-03-31 | Powered by Claude AI